rs782671712
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001173480.2(ARHGEF9):c.-64C>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000274 in 1,205,399 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 14 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001173480.2 5_prime_UTR_premature_start_codon_gain
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARHGEF9 | NM_001353921.2 | c.264C>T | p.Asn88Asn | synonymous_variant | 3/10 | ENST00000671741.2 | NP_001340850.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARHGEF9 | ENST00000671741.2 | c.264C>T | p.Asn88Asn | synonymous_variant | 3/10 | NM_001353921.2 | ENSP00000500715.1 |
Frequencies
GnomAD3 genomes AF: 0.0000179 AC: 2AN: 111611Hom.: 0 Cov.: 23 AF XY: 0.0000296 AC XY: 1AN XY: 33781
GnomAD3 exomes AF: 0.0000583 AC: 10AN: 171619Hom.: 0 AF XY: 0.000104 AC XY: 6AN XY: 57773
GnomAD4 exome AF: 0.0000283 AC: 31AN: 1093788Hom.: 0 Cov.: 31 AF XY: 0.0000361 AC XY: 13AN XY: 359852
GnomAD4 genome AF: 0.0000179 AC: 2AN: 111611Hom.: 0 Cov.: 23 AF XY: 0.0000296 AC XY: 1AN XY: 33781
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 05, 2019 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Developmental and epileptic encephalopathy, 8 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 07, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at